# Simmons First National Corp: financial statements, quarterly

SFNC · Nasdaq · CIK 90498 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sfnc.md) · [Financials](/companies/sfnc/financials.md) · [Filings](/companies/sfnc/filings.md) · [Insiders](/companies/sfnc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sfnc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [157](/filings/0001628280-23-037027.md) | [168 d](/filings/0001628280-24-007263.md) | [171](/filings/0001628280-24-021044.md) | [175](/filings/0001628280-24-035105.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.2](/filings/0001628280-24-046217.md) | [(4.5) d](/filings/0001628280-26-011618.md) | [6.1](/filings/0001628280-25-023690.md) | [6.0](/filings/0001628280-25-037719.md) | [0.8](/filings/0001628280-25-050112.md) | [5.7 d](/filings/0001628280-26-011618.md) | [5.8](/filings/0001628280-26-031205.md) | [8.9](/filings/0001628280-26-053273.md) | [(161)](/filings/0001628280-25-050112.md) | [15.9 d](/filings/0001628280-26-011618.md) | [17.5](/filings/0001628280-26-031205.md) | [16.7](/filings/0001628280-26-053273.md) |
| Net income | $m | [47.2](/filings/0001628280-24-046217.md) | [23.9 d](/filings/0001628280-26-011618.md) | [38.9](/filings/0001628280-25-023690.md) | [40.8](/filings/0001628280-25-037719.md) | [24.7](/filings/0001628280-25-050112.md) | [48.3 d](/filings/0001628280-26-011618.md) | [32.4](/filings/0001628280-26-031205.md) | [54.8](/filings/0001628280-26-053273.md) | [(563)](/filings/0001628280-25-050112.md) | [78.1 d](/filings/0001628280-26-011618.md) | [68.5](/filings/0001628280-26-031205.md) | [66.7](/filings/0001628280-26-053273.md) |
| Diluted EPS | $ per share | [0.37](/filings/0001628280-24-046217.md) | not reported | [0.31](/filings/0001628280-25-023690.md) | [0.32](/filings/0001628280-25-037719.md) | [0.20](/filings/0001628280-25-050112.md) | not reported | [0.26](/filings/0001628280-26-031205.md) | [0.43](/filings/0001628280-26-053273.md) | [(4.00)](/filings/0001628280-25-050112.md) | not reported | [0.47](/filings/0001628280-26-031205.md) | [0.46](/filings/0001628280-26-053273.md) |
| Basic EPS | $ per share | [0.38](/filings/0001628280-24-046217.md) | not reported | [0.31](/filings/0001628280-25-023690.md) | [0.32](/filings/0001628280-25-037719.md) | [0.20](/filings/0001628280-25-050112.md) | not reported | [0.26](/filings/0001628280-26-031205.md) | [0.43](/filings/0001628280-26-053273.md) | [(4.01)](/filings/0001628280-25-050112.md) | not reported | [0.47](/filings/0001628280-26-031205.md) | [0.46](/filings/0001628280-26-053273.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [27.6](/filings/0001628280-23-037027.md) | [27.3](/filings/0001628280-26-011618.md) | [27.4](/filings/0001628280-25-023690.md) | [27.4](/filings/0001628280-25-037719.md) | [27.3](/filings/0001628280-25-050112.md) | [26.9](/filings/0001628280-26-011618.md) | [26.8](/filings/0001628280-26-031205.md) | [26.7](/filings/0001628280-26-053273.md) | [24.2](/filings/0001628280-25-050112.md) | [24.5](/filings/0001628280-26-053273.md) | [24.7](/filings/0001628280-26-031205.md) | [24.8](/filings/0001628280-26-053273.md) |
| Total liabilities | $bn | [24.3](/filings/0001628280-23-037027.md) | [23.9](/filings/0001628280-25-008639.md) | [23.9](/filings/0001628280-24-021044.md) | [23.9](/filings/0001628280-24-035105.md) | [23.7](/filings/0001628280-24-046217.md) | [23.3](/filings/0001628280-26-011618.md) | [23.3](/filings/0001628280-25-023690.md) | [23.1](/filings/0001628280-25-037719.md) | [20.9](/filings/0001628280-25-050112.md) | [21.1](/filings/0001628280-26-053273.md) | [21.3](/filings/0001628280-26-031205.md) | [21.3](/filings/0001628280-26-053273.md) |
| Long-term debt | $bn | [0.4](/filings/0001628280-23-037027.md) | [0.4](/filings/0001628280-24-007263.md) | [0.4](/filings/0001628280-24-021044.md) | [0.4](/filings/0001628280-24-035105.md) | [0.4](/filings/0001628280-24-046217.md) | [0.4](/filings/0001628280-25-008639.md) | [0.4](/filings/0001628280-25-023690.md) | [0.4](/filings/0001628280-25-037719.md) | [0.7](/filings/0001628280-25-050112.md) | [0.3](/filings/0001628280-26-011618.md) | [0.3](/filings/0001628280-26-031205.md) | [0.3](/filings/0001628280-26-053273.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.3](/filings/0001628280-24-046217.md) | [3.4](/filings/0001628280-26-011618.md) | [3.4](/filings/0001628280-25-037719.md) | [3.5](/filings/0001628280-25-050112.md) | [3.5](/filings/0001628280-25-050112.md) | [3.5](/filings/0001628280-26-053273.md) | [3.5](/filings/0001628280-26-053273.md) | [3.5](/filings/0001628280-26-053273.md) | [3.4](/filings/0001628280-25-050112.md) | [3.4](/filings/0001628280-26-053273.md) | [3.4](/filings/0001628280-26-053273.md) | [3.5](/filings/0001628280-26-053273.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(38.5) d](/filings/0001628280-24-046217.md) | [421 d](/filings/0001628280-26-011618.md) | [57.6](/filings/0001628280-25-023690.md) | [86.1 d](/filings/0001628280-25-037719.md) | [199 d](/filings/0001628280-25-050112.md) | [82.9 d](/filings/0001628280-26-011618.md) | [32.8](/filings/0001628280-26-031205.md) | [77.6 d](/filings/0001628280-26-053273.md) | [223 d](/filings/0001628280-25-050112.md) | [116 d](/filings/0001628280-26-011618.md) | [40.3](/filings/0001628280-26-031205.md) | [145 d](/filings/0001628280-26-053273.md) |
| Capital expenditure | $m | [7.8 d](/filings/0001628280-24-046217.md) | [6.5 d](/filings/0001628280-26-011618.md) | [9.8](/filings/0001628280-25-023690.md) | [13.4 d](/filings/0001628280-25-037719.md) | [11.7 d](/filings/0001628280-25-050112.md) | [10.6 d](/filings/0001628280-26-011618.md) | [10.2](/filings/0001628280-26-031205.md) | [11.3 d](/filings/0001628280-26-053273.md) | [6.7 d](/filings/0001628280-25-050112.md) | [10.0 d](/filings/0001628280-26-011618.md) | [6.3](/filings/0001628280-26-031205.md) | [19.0 d](/filings/0001628280-26-053273.md) |
| Dividends paid | $m | [25.1 d](/filings/0001628280-24-046217.md) | [25.0 d](/filings/0001628280-26-011618.md) | [26.3](/filings/0001628280-25-023690.md) | [26.4 d](/filings/0001628280-25-037719.md) | [26.4 d](/filings/0001628280-25-050112.md) | [26.4 d](/filings/0001628280-26-011618.md) | [26.8](/filings/0001628280-26-031205.md) | [26.8 d](/filings/0001628280-26-053273.md) | [30.8 d](/filings/0001628280-25-050112.md) | [30.8 d](/filings/0001628280-26-011618.md) | [31.2](/filings/0001628280-26-031205.md) | [31.1 d](/filings/0001628280-26-053273.md) |
| Share repurchases | $m | [20.0 d](/filings/0001628280-24-046217.md) | [0.3 d](/filings/0001628280-26-011618.md) | not reported | not reported | [0.0 d](/filings/0001628280-24-046217.md) | [0.0 d](/filings/0001628280-26-011618.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [128](/filings/0001628280-23-037027.md) | [128](/filings/0001628280-24-021044.md) | [127](/filings/0001628280-24-035105.md) | [126](/filings/0001628280-24-046217.md) | [126](/filings/0001628280-25-023690.md) | [126](/filings/0001628280-25-037719.md) | [126](/filings/0001628280-25-050112.md) | [126](/filings/0001628280-26-031205.md) | [126](/filings/0001628280-26-053273.md) | [141](/filings/0001628280-25-050112.md) | [145](/filings/0001628280-26-031205.md) | [145](/filings/0001628280-26-053273.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 144,513,789 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053273.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.